Ryan W Morgan1, Robert M Sutton2, Adam S Himebauch2, Anna L Roberts3, William P Landis3, Yuxi Lin3, Jonathan Starr3, Abhay Ranganathan3, Nile Delso3, Constantine D Mavroudis4, Lindsay Volk4, Julia Slovis3, Alexandra M Marquez3, Vinay M Nadkarni2, Marco Hefti5, Robert A Berg2, Todd J Kilbaugh2. 1. Department of Anesthesiology and Critical Care Medicine, Children's Hospital of Philadelphia, United States; Department of Anesthesiology and Critical Care Medicine, Perelman School of Medicine at the University of Pennsylvania, United States. Electronic address: morganr1@email.chop.edu. 2. Department of Anesthesiology and Critical Care Medicine, Children's Hospital of Philadelphia, United States; Department of Anesthesiology and Critical Care Medicine, Perelman School of Medicine at the University of Pennsylvania, United States. 3. Department of Anesthesiology and Critical Care Medicine, Children's Hospital of Philadelphia, United States. 4. Department of Surgery, Division of Cardiothoracic Surgery, Children's Hospital of Philadelphia, United States. 5. Department of Pathology, University of Iowa Carver College of Medicine, United States.
Abstract
AIM: Inhaled nitric oxide (iNO) during cardiopulmonary resuscitation (CPR) improved systemic hemodynamics and outcomes in a preclinical model of adult in-hospital cardiac arrest (IHCA) and may also have a neuroprotective role following cardiac arrest. The primary objectives of this study were to determine if iNO during CPR would improve cerebral hemodynamics and mitochondrial function in a pediatric model of lipopolysaccharide-induced shock-associated IHCA. METHODS: After lipopolysaccharide infusion and ventricular fibrillation induction, 20 1-month-old piglets received hemodynamic-directed CPR and were randomized to blinded treatment with or without iNO (80 ppm) during and after CPR. Defibrillation attempts began at 10 min with a 20-min maximum CPR duration. Cerebral tissue from animals surviving 1-h post-arrest underwent high-resolution respirometry to evaluate the mitochondrial electron transport system and immunohistochemical analyses to assess neuropathology. RESULTS: During CPR, the iNO group had higher mean aortic pressure (41.6 ± 2.0 vs. 36.0 ± 1.4 mmHg; p = 0.005); diastolic BP (32.4 ± 2.4 vs. 27.1 ± 1.7 mmHg; p = 0.03); cerebral perfusion pressure (25.0 ± 2.6 vs. 19.1 ± 1.8 mmHg; p = 0.02); and cerebral blood flow relative to baseline (rCBF: 243.2 ± 54.1 vs. 115.5 ± 37.2%; p = 0.02). Among the 8/10 survivors in each group, the iNO group had higher mitochondrial Complex I oxidative phosphorylation in the cerebral cortex (3.60 [3.56, 3.99] vs. 3.23 [2.44, 3.46] pmol O2/s mg; p = 0.01) and hippocampus (4.79 [4.35, 5.18] vs. 3.17 [2.75, 4.58] pmol O2/s mg; p = 0.02). There were no other differences in mitochondrial respiration or brain injury between groups. CONCLUSIONS: Treatment with iNO during CPR resulted in superior systemic hemodynamics, rCBF, and cerebral mitochondrial Complex I respiration in this pediatric cardiac arrest model.
AIM: Inhaled nitric oxide (iNO) during cardiopulmonary resuscitation (CPR) improved systemic hemodynamics and outcomes in a preclinical model of adult in-hospital cardiac arrest (IHCA) and may also have a neuroprotective role following cardiac arrest. The primary objectives of this study were to determine if iNO during CPR would improve cerebral hemodynamics and mitochondrial function in a pediatric model of lipopolysaccharide-induced shock-associated IHCA. METHODS: After lipopolysaccharide infusion and ventricular fibrillation induction, 20 1-month-old piglets received hemodynamic-directed CPR and were randomized to blinded treatment with or without iNO (80 ppm) during and after CPR. Defibrillation attempts began at 10 min with a 20-min maximum CPR duration. Cerebral tissue from animals surviving 1-h post-arrest underwent high-resolution respirometry to evaluate the mitochondrial electron transport system and immunohistochemical analyses to assess neuropathology. RESULTS: During CPR, the iNO group had higher mean aortic pressure (41.6 ± 2.0 vs. 36.0 ± 1.4 mmHg; p = 0.005); diastolic BP (32.4 ± 2.4 vs. 27.1 ± 1.7 mmHg; p = 0.03); cerebral perfusion pressure (25.0 ± 2.6 vs. 19.1 ± 1.8 mmHg; p = 0.02); and cerebral blood flow relative to baseline (rCBF: 243.2 ± 54.1 vs. 115.5 ± 37.2%; p = 0.02). Among the 8/10 survivors in each group, the iNO group had higher mitochondrial Complex I oxidative phosphorylation in the cerebral cortex (3.60 [3.56, 3.99] vs. 3.23 [2.44, 3.46] pmol O2/s mg; p = 0.01) and hippocampus (4.79 [4.35, 5.18] vs. 3.17 [2.75, 4.58] pmol O2/s mg; p = 0.02). There were no other differences in mitochondrial respiration or brain injury between groups. CONCLUSIONS: Treatment with iNO during CPR resulted in superior systemic hemodynamics, rCBF, and cerebral mitochondrial Complex I respiration in this pediatric cardiac arrest model.
Authors: Ryan W Morgan; Alexis A Topjian; Yan Wang; Natalie J Atkin; Todd J Kilbaugh; Francis X McGowan; Robert A Berg; Laura Mercer-Rosa; Robert M Sutton; Adam S Himebauch Journal: Pediatr Crit Care Med Date: 2020-04 Impact factor: 3.624
Authors: Robert M Sutton; Stuart H Friess; Maryam Y Naim; Joshua W Lampe; George Bratinov; Theodore R Weiland; Mia Garuccio; Vinay M Nadkarni; Lance B Becker; Robert A Berg Journal: Am J Respir Crit Care Med Date: 2014-12-01 Impact factor: 21.405
Authors: Robert M Sutton; Benjamin French; Akira Nishisaki; Dana E Niles; Matthew R Maltese; Lori Boyle; Mette Stavland; Joar Eilevstjønn; Kristy B Arbogast; Robert A Berg; Vinay M Nadkarni Journal: Resuscitation Date: 2012-09-06 Impact factor: 5.262
Authors: Cameron Dezfulian; Sruti Shiva; Aleksey Alekseyenko; Akshay Pendyal; D G Beiser; Jeeva P Munasinghe; Stasia A Anderson; Christopher F Chesley; T L Vanden Hoek; Mark T Gladwin Journal: Circulation Date: 2009-08-24 Impact factor: 29.690
Authors: Cameron Dezfulian; Elizabeth Kenny; Andrew Lamade; Amalea Misse; Nicholas Krehel; Claudette St Croix; Eric E Kelley; Travis C Jackson; Thomas Uray; Justin Rackley; Patrick M Kochanek; Robert S B Clark; Hulya Bayir Journal: J Neurochem Date: 2016-10-03 Impact factor: 5.372
Authors: Ryan W Morgan; Robert M Sutton; Michael Karlsson; Andrew J Lautz; Constantine D Mavroudis; William P Landis; Yuxi Lin; Sejin Jeong; Nancy Craig; Vinay M Nadkarni; Todd J Kilbaugh; Robert A Berg Journal: Am J Respir Crit Care Med Date: 2018-04-01 Impact factor: 30.528